Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICASSO: Palifosfamide Tris Plus Doxorubicin in Soft-tissue Sarcoma
NCT00718484Phase 2Terminated
- Sponsor
- Alaunos Therapeutics
- Start
- Sep 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of palifosfamide in soft tissue sarcoma (STS), sponsored by Alaunos Therapeutics. Started Sep 2008; status: terminated.
02
Drugs
palifosfamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00718484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718484.